Recent studies revealed that mice haploinsufficient for Cav1.2 in prefrontal cortex exhibited antidepressant-like behavior53,54, while human patients with Cav1.2 gain-of-function mutants developed depression-related symptoms55,56. The gene discussed is CACNA1C; the disease is depressive disorder.